Prognosis

Biden Administration to Buy 10 Million Courses of Pfizer Covid Pill

  • U.S. also has bought 3.1 million courses of Merck’s treatment
  • Fauci warns that new treatments aren’t substitute for vaccine
Pfizer Soars After Covid Pill Results
Lock
This article is for subscribers only.

The Biden administration plans to buy enough of Pfizer Inc.’s new Covid-19 pill to treat 10 million patients, people familiar with the matter say.

Pfizer’s pill to treat the disease caused by the coronavirus showed extraordinary results in a clinical trial, reducing hospitalization and death by 89% among high-risk Covid-19 patients. The company said Tuesday it asked the U.S. Food and Drug Administration for emergency-use authorization for the pill, administered twice a day for five days.